Results 81 to 90 of about 344,680 (247)

Unlocking the therapeutic potential of selective CDK7 and BRD4 Inhibition against multiple myeloma cell growth

open access: yesHaematologica
Multiple myeloma (MM) is a plasma cell malignancy considered incurable despite the recent therapeutic advances. Effective targeted therapies are therefore needed.
Yao Yao   +7 more
doaj   +1 more source

Proteasome Inhibitors: Harnessing Proteostasis to Combat Disease [PDF]

open access: yes, 2020
The proteasome is the central component of the main cellular protein degradation pathway. During the past four decades, the critical function of the proteasome in numerous physiological processes has been revealed, and proteasome activity has been linked
Li, Jing, Sherman, David J.
core  

Multiple Myeloma [PDF]

open access: yesASH Image Bank, 2001
D, Samson, C, Singer
openaire   +3 more sources

Autologous peripheral blood stem cell transplantation as front-line therapy for myeloma with double-hit and triple-hit in a real-world study

open access: yesChinese Medical Journal, 2021
Guang-Zhong Yang   +6 more
doaj   +1 more source

Multiple-Myeloma proteins.I. Immunological studies [PDF]

open access: bronze, 1956
Leonhard Korngold, Rose Lipari
openalex   +1 more source

Daratumumab induces CD38 internalization and impairs myeloma cell adhesion

open access: yesOncoImmunology, 2018
Daratumumab (Dara), a human immunoglobulin G1 kappa (IgG1κ) monoclonal anti-CD38 antibody, has been approved by the U.S. Food and Drug Administration for the treatment of relapsed multiple myeloma (MM) as a single agent as well as in combination with ...
Jayeeta Ghose   +17 more
doaj   +1 more source

FRACTIONATION OF SERUM PROTEINS IN HYPERPROTEINEMIA, WITH SPECIAL REFERENCE TO MULTIPLE MYELOMA [PDF]

open access: bronze, 1941
Alexander B. Gutman   +4 more
openalex   +1 more source

A CASE OF MULTIPLE MYELOMA, [PDF]

open access: green, 1910
OwenT Williams, EA. Evans, Ernest Glynn
openalex   +1 more source

Home - About - Disclaimer - Privacy